Hong Bu

7.3k total citations
238 papers, 5.1k citations indexed

About

Hong Bu is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Hong Bu has authored 238 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 60 papers in Surgery and 60 papers in Cancer Research. Recurrent topics in Hong Bu's work include Breast Cancer Treatment Studies (32 papers), Tissue Engineering and Regenerative Medicine (23 papers) and Radiomics and Machine Learning in Medical Imaging (23 papers). Hong Bu is often cited by papers focused on Breast Cancer Treatment Studies (32 papers), Tissue Engineering and Regenerative Medicine (23 papers) and Radiomics and Machine Learning in Medical Imaging (23 papers). Hong Bu collaborates with scholars based in China, United States and Sweden. Hong Bu's co-authors include Yujun Shi, Ji Bao, Yongjie Zhou, Yi Li, Qiong Wu, Feng Lin, Yujia Wang, Li Li, Zhidan Tu and Bing Wei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hong Bu

232 papers receiving 5.1k citations

Peers

Countries citing papers authored by Hong Bu

Since Specialization

Citations

This map shows the geographic impact of Hong Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Bu more than expected).

Fields of papers citing papers by Hong Bu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Bu. The network helps show where Hong Bu may publish in the future.

Co-authorship network of co-authors of Hong Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Bu. A scholar is included among the top collaborators of Hong Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Bu. Hong Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	<b>Experts' </b><b>C</b><b>ognition-Driven Ensemble Deep Learning </b><b>f</b><b>or External Validation of Predicting Pathological Complete Response to Neoadjuvant Chemotherapy </b><b>f</b><b>rom Histological Images in Breast Cancer</b> 2024 ·Yongquan Yang, Fengling Li, (unknown), Yuanyuan Zhao, (unknown), Xiuli Xiao, Hong Bu	2
2	S100a4+ alveolar macrophages accelerate the progression of precancerous atypical adenomatous hyperplasia by promoting the angiogenic function regulated by fatty acid metabolism 2024 ·eLife ·(unknown), Ying Yang, (unknown), (unknown), (unknown), (unknown), Tingting Song, Yilong Wang, Zhiqiang Liu, Hong Bu, Li Zhang, Le Zhang	3
3	Brahma‐Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion 2021 ·Hepatology ·Yongjie Zhou, Yuwei Chen, Xiaoyun Zhang, Qing Xu, Zhenru Wu, Xiaoyue Cao, Mingyang Shao, (unknown), Tao Lv, Changli Lu, Mingjun Xie, Tianfu Wen, Jiayin Yang, Yujun Shi, Hong Bu	25
4	How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies 2021 ·npj Breast Cancer ·Xinran Wang, Liang Wang, Hong Bu, Ningning Zhang, Yue Meng, (unknown), (unknown), (unknown), Yanan Wang, Xin Xu, (unknown), (unknown), (unknown), Kuan Tian, Xiao Han, Junzhou Huang, Jianhua Yao, Yueping Liu	31
5	Multidimensional Machine Learning Personalized Prognostic Model in an Early Invasive Breast Cancer Population-Based Cohort in China: Algorithm Validation Study 2020 ·JMIR Medical Informatics ·Xiaorong Zhong, Ting Luo, Ling Deng, Pei Liu, Kejia Hu, Donghao Lu, (unknown), (unknown), Yuxin Xie, Jiayuan Li, (unknown), Tianjie Pu, Feng Ye, Hong Bu, Bo Fu, Hong Zheng	10
6	Immune Profiles of Tumor Microenvironment and Clinical Prognosis among Women with Triple-Negative Breast Cancer 2019 ·Cancer Epidemiology Biomarkers & Prevention ·Ling Deng, Donghao Lu, Yingnan Bai, Yanping Wang, Hong Bu, Hong Zheng	44
7	A multiple breast cancer stem cell model to predict recurrence of T1–3, N0 breast cancer 2019 ·BMC Cancer ·Yan Qiu, Liya Wang, Xiaorong Zhong, Li Li, Fei Chen, Xiao Lin, Fangyu Liu, Bo Fu, Hong Zheng, Feng Ye, Hong Bu	11
8	[Feasibility of amplicon-based targeted next-generation sequencing of colorectal cancer in endoscopic biopsies]. 2018 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Hong Bu	1
9	[Ki-67 expression and its effect on response to neo-adjuvant chemotherapy in invasive breast cancer]. 2017 ·PubMed ·Xiaoxia Wei, (unknown), Tianjie Pu, Libo Yang, (unknown), Hong Bu	3
10	[China National Guideline of Classification, Diagnosis and Treatment for Lung Nodules (2016 Version)]. 2016 ·SHILAP Revista de lepidopterología ·Qinghua Zhou, Yaguang Fan, Ying Wang, You‐Lin Qiao, Guiqi Wang, Yunchao Huang, Xingyun Wang, Ning Wu, (unknown), Xiangpeng Zheng, Hong Bu	42
11	Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice 2016 ·Journal of Experimental & Clinical Cancer Research ·(unknown), Yongjie Zhou, Hong Bu, Tao Lv, Yujun Shi, Jiayin Yang	118
12	[Evaluation of immunohistochemistry HER2 results interpretation in invasive micropapillary carcinoma of the breast]. 2015 ·PubMed ·Wenjuan Yang, Bing Wei, Min Chen, Hong Bu	6
13	ALDH+/CD44+ cells in breast cancer are associated with worse prognosis and poor clinical outcome 2015 ·Experimental and Molecular Pathology ·Yan Qiu, Tianjie Pu, Peng Guo, Bing Wei, Zhang Zhang, Hongying Zhang, Xiaorong Zhong, Hong Zheng, Lina Chen, Hong Bu, Feng Ye	20
14	Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples. 2015 ·PubMed ·Tianjie Pu, Peng Guo, Yan Qiu, (unknown), Libo Yang, (unknown), Feng Ye, Hong Bu	8
15	Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies 2013 ·Cell Death and Disease ·(unknown), Tong Chen, (unknown), (unknown), (unknown), Ran Lu, (unknown), Xikun Zhou, (unknown), (unknown), (unknown), You Lü, (unknown), Hong Bu, (unknown), (unknown)	56
16	[Prognostic factors of breast cancer]. 2011 ·PubMed ·Ping Tang, Bing Wei, Wenjuan Yang, (unknown), Hong Bu	3
17	[Molecular phenotypes of breast cancer and their clinical application]. 2009 ·PubMed ·Ping Tang, Bing Wei, David G. Hicks, Kristin A. Skinner, Hong Bu	1
18	Clinicopathologic features of pleomorphic hyalinizing angiectatic tumor of soft parts 2007 ·Chinese Medical Journal ·Ke Qi, (unknown), Hongying Zhang, Hong Bu, Sheng Li, Danni Shi, Guanghua Yang, Huijiao Chen, Bing Wei	29
19	Myofibroblastic sarcoma of the nasal cavity and paranasal sinus: a clinicopathologic study of 6 cases and review of the literature 2006 ·Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology ·(unknown), Hongying Zhang, Hong Bu, Guanghua Yang, Xianliang Zhang, Yang Guo	38
20	[HER2 expression and its prognostic implication in lymph node negative breast carcinoma: a Meta-analysis]. 2005 ·PubMed ·Hua Guo, Bing Wei, Hongying Zhang, Guanjian Liu, Hong Bu, (unknown), Xi Tang, Qingqing Dai, Huijiao Chen, Yong Zhou	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact